Please find attached the intimation regarding receipt of ANVISA, Brazil GMP certificate for the Company''s Manufacturing facility located at Kakinada, Andhra Pradesh.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tyche Industries has received a Good Manufacturing Practice (GMP) Compliance Certificate from ANVISA, Brazil's health regulatory agency, for its manufacturing facility at Kakinada, Andhra Pradesh. This follows the successful completion of a GMP inspection by ANVISA, which was earlier intimated on September 11, 2025. The certificate is valid for two years, from March 16, 2026 to March 16, 2028. The ANVISA certification is a key regulatory requirement for pharmaceutical companies looking to manufacture and supply products to the Brazilian market. With this approval, Tyche Industries is now positioned to tap into the Brazilian pharmaceutical market through its Kakinada facility.
Positive for shareholders — the ANVISA GMP clearance opens the door to Brazil's pharmaceutical market, potentially boosting export revenue and long-term growth prospects. The two-year validity provides a solid window to secure orders and scale exports.